Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS Rector takes three months sabbatical leave
2008-05-05

The Rector of the University of the Free State (UFS), Prof. Frederick Fourie, has announced that he will be taking three months sabbatical leave as from Thursday, 8 May 2008.

Prof. Fourie recently made the request for sabbatical leave to the Chairperson of the UFS Council, Judge Faan Hancke. The request was approved given the fact that Prof. Fourie has occupied a number of demanding top-management posts for almost nine years, during which time he had to manage a number of major changes at the UFS.

According to Prof. Fourie, he originally wanted to go on sabbatical leave in the second half of 2007 before the start of his second term as rector, but it was not possible at that stage.

He was last on sabbatical in 1996 before he became Dean of the Faculty of Economic and Management Sciences in 1997 and Vice-Rector: Academic Operations in 1999.

He could not take his next five-yearly leave because in the post of vice-rector he was tasked with leading the financial-turnaround strategy for the UFS from the year 2000 and had to act as rector when the previous rector, Prof. Stef Coetzee, was on sick leave. Since being inaugurated as rector in 2003, there was also no opportunity to take leave as a result of the many key projects and urgent initiatives.

The Vice-Rector: Academic Operations and vice-chairperson of the Senate, Prof. Teuns Verschoor, will be the acting rector. Management processes and decision-making will continue as normal under the leadership of the acting rector together with the Executive Committee of the Executive Management (Exco) and the Executive Management. This applies to the decision about the future of the Reitz Residence as well as the continuing implementation of the policy on diversity in student residences.

According to Judge Hancke it was important that Prof. Fourie took sabbatical leave in the light of the long period he has been at the forefront of very demanding changes. There are many challenges that still lie ahead.

During his leave Prof. Fourie will be involved with the Higher Education South Africa (HESA) investigation into diversity and racism on campuses, with research and a national conference on institutional culture, as well as the Association of Commonwealth Universities (ACU) benchmarking project and its conference in Australia at the end of August 2008.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept